Clinical experience with perindopril in African-American hypertensive patients: a large United States community trial.

@article{Cohn2004ClinicalEW,
  title={Clinical experience with perindopril in African-American hypertensive patients: a large United States community trial.},
  author={Jay N. Cohn and Stevo Julius and Joel M. Neutel and Michael D Weber and Prasad Turlapaty and Yannan Shen and Victor M Dong and Alicia Batchelor and Weinong Guo and Hjalmar Lagast},
  journal={American journal of hypertension},
  year={2004},
  volume={17 2},
  pages={134-8}
}
BACKGROUND The prevalence of hypertension is greater in African Americans, and management of this condition presents challenges for practicing physicians. METHODS The effectiveness and safety of perindopril was evaluated in hypertensive African-American patients (n = 1412) and hypertensive white patients (n = 7745) who had participated in a large United States community trial. Patients received perindopril 4 mg once daily for 6 weeks. Based on physicians' clinical judgment at week 6, the dose… CONTINUE READING